Overview

Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Clinical investigation of anti-psoriatic efficacy and atrophy
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Almirall, S.A.
Collaborator:
proDERM GmbH